Notice: Prescription Drug List (PDL): Vitamin D

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-09-30

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data